Conference Coverage

Migraine is often a deciding factor in pregnancy planning


 

FROM AHS 2020

More education needed

Commenting on the study, Susan Hutchinson, MD, director of the Orange County Migraine and Headache Center, Irvine, California, said that not knowing how pregnancy is going to affect patients’ migraines can be “very scary” for women. In addition, patients often wonder what migraine treatments they can safely take once they do become pregnant, said Dr. Hutchinson, who was not involved in the research.

She noted that advantages of the ARMR data are that they are derived from a multicenter study and that migraine diagnoses were made by a headache specialist. A potential limitation of the study is that the population may not reflect outcomes of the millions of women who have migraine and become pregnant but never see a specialist.

“These findings show that more education is needed,” Dr. Hutchinson said.

Most women, especially those who have migraine without aura, note improvement with migraine during pregnancy, primarily because of the high, steady levels of estradiol, especially in the second and third trimesters, she said. In light of this, neurologists should reassure women that migraine is not a contraindication to pregnancy, she added.

There is also a need for additional research to assess how past experience with migraine and pregnancy influences a woman’s comfort level with additional pregnancies. Studies as to which treatments are safest for acute and preventive treatment of migraine during prepregnancy, pregnancy, and lactation are also needed, Dr. Hutchinson noted.

“If women knew they had treatment options that were evidence-based, they might be much more comfortable contemplating a pregnancy,” she said.

Dr. Ishii and Dr. Hutchinson have disclosed no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Antibody cleared amyloid plaques, slowed cognitive decline
MDedge ObGyn
Study: Problems persist with APMs
MDedge ObGyn
Antimigraine agents in pregnancy and lactation
MDedge ObGyn
Active migraine in women linked to lower risk of developing T2DM
MDedge ObGyn
Prenatal valproate exposure raises ADHD risk
MDedge ObGyn
Valproate, topiramate prescribed in young women despite known teratogenicity risks
MDedge ObGyn
Postdural puncture headache linked to increased risk of subdural hematoma
MDedge ObGyn
How can neurologists diagnose and treat menstrual migraine?
MDedge ObGyn
Daily Recap 6/17
MDedge ObGyn
Daily Recap: Lung ultrasound helps diagnose COVID-19 in kids, first treatment approved for adult-onset Still’s disease
MDedge ObGyn